Development of diclofenac sodium releasing bio-erodible polymeric nanomats

被引:31
作者
Piras, A. M.
Nikkola, L.
Chiellini, F.
Ashammakhi, N.
Chiellini, E. [1 ]
机构
[1] Univ Pisa, Dept Ind & Engn Chem, Pisa, Italy
[2] Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland
[3] Univ Pisa, INSTM Consortium Reference Ctr, Lab Bioact Polymer Mat Biomed & Environm Applicat, Pisa, Italy
关键词
electrospinning; nanotechnology; nanofibers; drug release; bioerodible polymers;
D O I
10.1166/jnn.2006.486
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Application of nanofiber-based nanomats in medicine is attractive and thanks to the 3D nano-structure and the high surface to volume ratio they are excellent for local controlled drug delivery. The use of bioactive bioerodible polymers for developing drug delivery nanomats may allow for drug release and targeting control. Objective of the current study was to evaluate the suitability of bioerodible polymeric material based on n-butyl hemiester of [poly(maleic anhydride-alt-2-methoxyethyl vinyl ether)] (PAM14) for the preparation of nanomats for controlled administration of anti-inflammatory, diclofenac sodium (DS) drug. Samples were prepared using different polymer concentrations (5-10%) in either ethanol or acetic acid as solvent. Morphology was investigated by using scanning electron microscopy (SEM). Thermal analysis such as differential scanning calorimetry (DSC) was performed to detect effect on polymer arrangement. DS localization in electrospun nanomats was evaluated by using electron back scattering microanalysis, based on the detection of chlorine, and drug release kinetics was assessed using UV-Vis. Average fiber diameter resulted in the range of 100 nm to 1.0 mu m and a homogeneous distribution of the loaded drug into the fibers was observed. The DS release was immediate and despite the preliminary nature of the performed electrospinning experiments, the achieved results appear promising for the future development of a novel system for the controlled and targeted administration of drug and active agent.
引用
收藏
页码:3310 / 3320
页数:11
相关论文
共 48 条
[1]
[Anonymous], [No title captured], Patent No. 0154667
[2]
Electrospun chitosan-based nanofibers and their cellular compatibility [J].
Bhattarai, N ;
Edmondson, D ;
Veiseh, O ;
Matsen, FA ;
Zhang, MQ .
BIOMATERIALS, 2005, 26 (31) :6176-6184
[3]
Electrospinning collagen and elastin: Preliminary vascular tissue engineering [J].
Boland, ED ;
Matthews, JA ;
Pawlowski, KJ ;
Simpson, DG ;
Wnek, GE ;
Bowlin, GL .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :1422-1432
[4]
BOLGEN N, 2005, 6 INT S FRONT BIOM P
[5]
Processing and microstructural characterization of porous biocompatible protein polymer thin films [J].
Buchko, CJ ;
Chen, LC ;
Shen, Y ;
Martin, DC .
POLYMER, 1999, 40 (26) :7397-7407
[6]
Therapy for intra-abdominal adhesions [J].
Bullen, TF ;
Hershman, MJ .
HOSPITAL MEDICINE, 2004, 65 (06) :340-342
[7]
Sustained release of proteins from electrospun biodegradable fibers [J].
Chew, SY ;
Wen, J ;
Yim, EKF ;
Leong, KW .
BIOMACROMOLECULES, 2005, 6 (04) :2017-2024
[8]
Targeted administration of proteic drugs. I. Preparation of polymeric nanoparticles [J].
Chiellini, E ;
Chiellini, EE ;
Chiellini, F ;
Solaro, R .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2001, 16 (06) :441-465
[9]
MULTIFUNCTIONAL BIOERODIBLE BIODEGRADABLE POLYMERIC MATERIALS [J].
CHIELLINI, E ;
SOLARO, R .
MACROMOLECULAR SYMPOSIA, 1995, 98 :803-824
[10]
Controlled deposition of electrospun poly(ethylene oxide) fibers [J].
Deitzel, JM ;
Kleinmeyer, JD ;
Hirvonen, JK ;
Tan, NCB .
POLYMER, 2001, 42 (19) :8163-8170